Clinical Trial

Studying Patient Experiences in Osteoporosis Clinical Trials

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 10, 2023 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Clinical trials for osteoporosis are designed to assess the safety and effectiveness of novel osteoporosis treatments. These trials play a crucial role in establishing whether these new treatments outperform existing options and provide substantial evidence to support their adoption within the wider population. The primary aim of this particular study is to investigate the experiences of individuals diagnosed with osteoporosis who participate in a distinct clinical trial involving a medical intervention. The focus will be on closely monitoring the rates of trial completion and withdrawal among these participants.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05937945
Lead Sponsor Power Life Sciences Inc.
Conditions Osteoporosis
Enrollment 500 participants
Start Date 2024-07
Primary Completion 2025-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2023-07-10